156P Molecularly driven therapy recommended by a molecular tumor board: Accessible option or privilege for a minority of patients? A single-center experience from the Czech Republic

Saved in:
Bibliographic Details
Published inESMO open Vol. 8; no. 1; p. 102005
Main Authors Eid, M., Tucek, S., Bednarikova, M., Brancikova, D., Slaby, O.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.10.2023
Online AccessGet full text

Cover

More Information
ISSN:2059-7029
2059-7029
DOI:10.1016/j.esmoop.2023.102005